Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial-Reference-Cited by-同舟云学术

Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial

Published:2019-04-29 Issue:1 Volume:28 Page:261-269
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Gunn G. Brandon,Mendoza Tito R.,Garden Adam S.,Wang Xin Shelley,Shi Qiuling,Morrison William H.,Frank Steven J.,Phan Jack,Fuller Clifton D.,Chambers Mark S.,Hanna Ehab Y.,Lu Charles,Rosenthal David I.,Cleeland Charles S.

Funder

National Cancer Institute

The University of Texas MD Anderson Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-019-04791-4.pdf

Reference23 articles.

1. Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, Gunn GB, Beadle BM, Ang KK, Rosenthal DI, Sturgis EM (2013) Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol 8(21). https://doi.org/10.1186/1748-717X-8-21

2. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB (2014) Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975–1984. https://doi.org/10.1002/cncr.28672

3. Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, Hubbard RM, Barrow MP, Hutcheson KA (2017) Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head Neck 39(11):2151–2158. https://doi.org/10.1002/hed.24879

4. Mirghani H, Blanchard P (2018) Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand? Clin Transl Radiat Oncol 8:4–11. https://doi.org/10.1016/j.ctro.2017.10.005

5. Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21(2):153–160. https://doi.org/10.1016/j.bbi.2006.09.006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minocycline alleviates lipopolysaccharide-induced cardiotoxicity by suppressing the NLRP3/Caspase-1 signaling pathway;Scientific Reports;2024-09-11

2. 34 Impact of antibiotic use in the primary treatment of nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-03

3. MINOCYCLINE DECLINES INTERLEUKIN-1Β-INDUCED APOPTOSIS AND MATRIX METALLOPROTEINASE EXPRESSION IN C28/I2 CHONDROCYTE CELLS: AN IN VITRO STUDY ON OSTEOARTHRITIS;EXCLI J;2024

4. Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats;Scientific Journal of Kurdistan University of Medical Sciences;2023-12-01

5. Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22